Selected Publications

Academic Article

Year Title Altmetric
2019 Outcome for pediatric acute promyelocytic leukemia patients at Children's Oncology Group sites on the Leukemia Intergroup Study CALGB 9710 (Alliance)Medical and Pediatric Oncology.  66. 2019
2019 Risk Markers for Significant Bleeding and Thrombosis in Pediatric Acute Promyelocytic Leukemia; Report from the Children's Oncology Group Study AAML0631Journal of Pediatric Hematology/Oncology.  41:51-55. 2019
2018 Acute myelogenous leukemia in adolescents and young adultsMedical and Pediatric Oncology.  65. 2018
2018 Quality Initiative to Improve time to Antibiotics for Febrile Pediatric Patients with Potential Neutropenia.Pediatric Quality and Safety.  3:e095. 2018
2018 Incidence and outcomes of paediatric myelodysplastic syndrome in the United StatesBritish Journal of Haematology.  180:898-901. 2018
2018 Blinatumomab activity in a patient with Down syndrome B-precursor acute lymphoblastic leukemiaMedical and Pediatric Oncology.  65. 2018
2017 Arsenic trioxide consolidation allows anthracycline dose reduction for pediatric patients with acute promyelocytic leukemia: Report from the children’s oncology group phase III historically controlled trial AAML0631Journal of Clinical Oncology.  35:3021-3029. 2017
2017 Extramedullary Relapse of Acute Lymphoblastic Leukemia Presenting as Abnormal Uterine Bleeding: A Case ReportJournal of Pediatric and Adolescent Gynecology.  30:431-434. 2017
2016 Management of relapsed and refractory childhood acute promyelocytic leukaemia: recommendations from an international expert panelBritish Journal of Haematology.  175:588-601. 2016
2016 Protocol for Reducing Time to Antibiotics in Pediatric Patients Presenting to an Emergency Department with Feer and Neutropenia: Efficacy and BarriersPediatric Emergency Care.  32:739-745. 2016
2015 Ethnic variation of TET2 SNP rs2454206 and association with clinical outcome in childhood AML: A report from the Children's Oncology GroupLeukemia.  29:2424-2426. 2015
2015 Inclusion of Adolescents and Young Adults in Cancer Clinical TrialsSeminars in Oncology Nursing.  31:197-205. 2015
2014 Treatment of paediatric APL: How does the therapeutic approach differ from adults?Baillieres Clinical Haematology.  27:69-78. 2014
2013 Mutations in the DNMT3A exon 23 independently predict poor outcome in older patients with acute myeloid leukemia: A SWOG reportLeukemia.  27:238-241. 2013
2012 FLT3 mutation status is a predictor of early death in pediatric acute promyelocytic leukemia: A report from the Children's Oncology GroupMedical and Pediatric Oncology.  59:662-667. 2012
2011 Leukemic mutations in the methylation-associated genes DNMT3A and IDH2 are rare events in pediatric AML: A report from the Children's Oncology GroupMedical and Pediatric Oncology.  57:204-209. 2011


Year Title Altmetric
2017 Acute Myelogenous Leukemia.  135-149. 2017

Education And Training

  • Doctor of Medicine, Vanderbilt University 2005
  • Bachelor of Arts in Biomedical Sciences, Brown University 2000
  • Vanderbilt Children's Hospital, Internship 2006
  • Vanderbilt Children's Hospital, Residency 2008
  • University of Washington Medical Center, Postdoctoral Fellowship 2011
  • Full Name

  • Matthew Kutny